Cargando…
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
BACKGROUND: Autophagy regulates innate and adaptive immune responses to pathogens and tumors. We have reported that autophagosomes derived from tumor cells after proteasome inhibition, DRibbles (Defective ribosomal products in blebs), were excellent sources of antigens for efficient cross priming of...
Autores principales: | Ye, Wei, Xing, Yun, Paustian, Christopher, van de Ven, Rieneke, Moudgil, Tarsem, Hilton, Traci L, Fox, Bernard A, Urba, Walter J, Zhao, Wei, Hu, Hong-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021424/ https://www.ncbi.nlm.nih.gov/pubmed/24735498 http://dx.doi.org/10.1186/1479-5876-12-100 |
Ejemplares similares
-
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014) -
Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013) -
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
por: Page, David B., et al.
Publicado: (2016) -
Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014) -
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)